Table 1.
Description of cats included in the study.
| Cat | Group | Signalment | IRIS stage and creatinine (mg/dl) | Treatment |
|---|---|---|---|---|
| 1 | Young healthy | 1.5-year MC DSH | IRIS: N/A Creatinine: 1.7 UPC: 0.1 | 1×105 bmMSC injected into the right kidney |
| 2 | Young healthy | 1.5-year FI DSH | IRIS: N/A Creatinine: 1.3 UPC: 0.1 | 1×105 bmMSC injected into the left kidney |
| 3 | CKD+bmMSC | 6-year-old MC DLH | IRIS: IV Creatinine: 5.4 UPC: 1.7 | 1×105 bmMSC injected into the left kidney |
| 4 | CKD+bmMSC | 15-year MC Tonkinese | IRIS: III Creatinine: 4.3 UPC: 0.3 | Unable to expand sufficient bmMSC for therapy |
| 5 | CKD+bmMSC | 17-year MC Siamese | IRIS: II Creatinine: 2.6 UPC: not performed | Unable to expand sufficient bmMSC for therapy |
| 6 | CKD+bmMSC | 14-year MC DSH | IRIS: II Creatinine: 2.0 UPC: 0.2 | Unable to expand sufficient bmMSC for therapy |
| 7 | CKD+aMSC | 9-year FS Siamese | IRIS: III Creatinine: 3.5 UPC: 0.1 | 1×106 aMSC injected into the left kidney |
| 8 | CKD+aMSC | 9-year MC DSH | IRIS: II Creatinine: 2.6 UPC: 0.2 | 2×106 aMSC injected into the left kidney |
| 9 | CKD+aMSC | 7-year MC DSH | IRIS: IV Creatinine: 6.5 UPC: 0.3 | 4×106 aMSC injected into the left kidney |
| 10 | CKD no MSC | 9-year MC DSH | IRIS: II Creatinine: 2.3 UPC: 0.3 | GFR repeatability only |
| 11 | CKD no MSC | 12-year FS DSH | IRIS: III Creatinine: 3.3 UPC: 0.1 | GFR repeatability only |
| 12 | CKD no MSC | 13-year MC DSH | IRIS: II Creatinine: 2.6 UPC: 0.2 | GFR repeatability only |
DSH=domestic shorthair, FS=female spayed, MC=male castrated; IRIS=Internation Renal Interest Society.